Welcome to the Clinical area of Sana Health
Before continuing, please read.
You are entering the Clinical area of the Sana Health website. The data in this area is intended for use by:
Healthcare professionals
Investigators currently participating in Sana Health clinical trials or those actively requesting additional information about clinical trials
The Sana Device is FDA De Novo cleared as an adjunctive treatment for temporary relief of neuropathic pain in patients aged 18 and older (21 CFR 890.5775). Some content in this section includes future-looking statements and clinical data regarding uses of the device beyond its current cleared indication. This content does not constitute a recommendation for use of the Sana Device for those purposes, as additional indications require completion of the FDA review process.
If you are a clinical study participant looking for instructions for use for your clinical study device, please contact our Customer Service Team at 720-310-3370 or support@sana.io.
If you are interested in volunteering for future clinical trials, please email clinicalinquiry@sana.io.
BY CONTINUING INTO THESE PAGES YOU ACKNOWLEDGE THE ABOVE.
Interested in joining a future clinical trial with Sana Health?
Clinical Publications
A Pilot Investigation of the Effectiveness of the Sana Device in Management of PTSD: A Blinded Randomized Controlled Trial has been published by the Journal of Traumatic Stress Disorders & Treatment.
The publication explores the effectiveness of the Sana device, a non-invasive wearable device, in managing symptoms of PTSD*. This pilot randomized controlled trial used blinded methods to assess its impact compared to a control group. Preliminary results indicate that the device may help reduce PTSD symptoms, improve sleep quality, and lower anxiety levels. The findings support further research into the device as a potential therapeutic tool for PTSD management. Read the full publication here.
*The Sana Device is not cleared for the management of PTSD in any geography at this time, clinical investigations are ongoing.
Quality of life was improved for subjects in DOD-funded PTSD study*
*Full results are on file at Sana Health.
Results from RCT Neuropathic Pain Study show statistically significant improvement in pain symptoms*
Sana Health’s pivotal Neuropathic Pain data has been submitted to the FDA for a De Novo.
*Full results are on file at Sana Health.